Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Panbio Inc

Established in 1988 and listed on the Australian Stock Exchange in 2001, Panbio Limited is an Australian-based international diagnostics company. With a mission of “better tests for more people”, the Company develops, manufactures and markets innovative diagnostic tests to aid in the diagnosis of infectious disease. The Company is recognized as a world leader in tests used in the diagnosis of flavivirus and other arthropod-borne virusesWith a product portfolio covering over 30 infectious diseases, the company supports pathology laboratories and physicians in Australia, Asia, the Americas, Europe, the Middle East and Africa.
Panbio has a history of market leadership in response to diseases that afflict millions of people and was ‘first to market’ with diagnostics for dengue fever, Ross River fever and West Nile encephalitis.
Its range of technical platforms includes enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody test (IFA) and rapid lateral flow devices.
The Company’s strategic partnerships include customers, distributors, other manufacturers and some of the world’s leading research organisations.
In the past year, Panbio received US FDA clearance for its second generation West Nile virus test, received the first orders for its new Dengue ‘Point of Care’ cassette and signed research agreements to develop improved diagnostics for Japanese encephalitis, leptospirosis and malaria.
In research, Panbio is pursuing two significant improvements in the development of in vitro diagnostic assays.
The first involves a two-year project to develop a novel homogeneous assay for the diagnostics market. If successful, clinical diagnostic tests that currently require up to three hours will be processed in a matter of minutes – a dramatic breakthrough by Panbio.


Contact Details:
9075 Guilford Road
Columbia
Maryland
21046
United States of America
Tel:1 410 381 8550
Fax: 1 410 381 8984
Email:panbio@panbio.com
WWW:

www.panbio.com.au/




Loading...

BioNews Results for Panbio Inc:

Adherex Technologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 7:07AM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Ralcorp Holdings Inc, Aqua America Inc, MetroPCS C
Guru Focus:  Nov 16 2009 3:51AM Matching: inc
AngioDynamics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 5:28AM Matching: inc
Advaxis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 7:02AM Matching: inc
Alcon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 6:25AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Panbio Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 550 times since April 2007, the link to the organisation's website has been followed 83 times

Recent Search Terms used to find this page: panbio laboratories | panbio inc. australia leptospira order | panbio diagnostics | PANBIO INC | panbio | panbio west nile test | .

Search for more companies in Columbia

Search for more companies in Maryland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Panbio Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.